$ZTS News

ZTS Wins European Commission Approval for New Poultry Disease Vaccine

Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND

Zoetis Announces EC Grants Marketing Authorization For Poulvac Procerta HVT-ND, Recombinant Vector Vaccine For Protection Of Chickens Against Newcastle Disease And Marek’s Disease Viruses

HSBC Maintains Buy on Zoetis, Lowers Price Target to $95

Zoetis: The 60% Decline Was Justified, But Shares Are Finally Buyable

Zoetis Inc (NYSE:ZTS) Offers High-Quality Dividend Growth and Strong Profitability at a Discount

Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest

Zoetis (ZTS) Index Shift: A Harbinger for Its Competitive Moat in Companion-Animal Health?

This Analyst Thinks Stabilization For Zoetis’ Products ‘Could Be Several Quarters Away’

Barclays Maintains Equal-Weight on Zoetis, Lowers Price Target to $85

TD Cowen Maintains Buy on Zoetis, Lowers Price Target to $104

Is Zoetis Inc. (ZTS) A Good Stock To Buy Now?

Zoetis (ZTS) Suffers a Larger Drop Than the General Market: Key Insights

Stifel Maintains Hold on Zoetis, Lowers Price Target to $85

Zoetis to Host Webcast and Conference Call on Second Quarter 2026 Financial Results

Zoetis (ZTS) Lost 22% in a Day; What Has Wall Street Worried?

Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing

ZOETIS INC (NYSE:ZTS) Shows Strong Value Potential with Attractive Valuation and High Profitability

What Makes Zoetis (ZTS) an Attractive Bet?

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts